Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P1.13-14 the Molecular Landscape of Lung Adenocarcinomas With Activating EGFR Gene Mutations Determined by Targeted-Sequencing

Journal of Thoracic Oncology

English

P1.15-13 Wait Times for Diagnosis and Treatment of Lung Cancer Across the Province of Quebec, Canada

Journal of Thoracic Oncology

English

P2.01-55 Dual-Energy CT Scan to Evaluate Sarcopenia in Lung Cancer in Comparison With Conventional CT Scan

Journal of Thoracic Oncology

English

P1.14-06 Treatment Outcomes of Patients With Thymic Carcinoma: A Monocentric Experience of Sequential Regimens Modality

Journal of Thoracic Oncology

English

P1.15-20 Diagnosis and Treatment Delay Among Patients With Lung Cancer in Mexican Population

Journal of Thoracic Oncology

English

P3.03-12 Cyclic Mechanical Strain and Myoferlin Modulates Lung Adenocarcinoma Cell Proliferation and Erlotinib Resistance

Journal of Thoracic Oncology

English

P1.16-45 Thoracoscopic Stapler-Based Complex Segmentectomy Assisted by Virtual Assisted Lung Mapping

Journal of Thoracic Oncology

English

P3.16-10 Radiomic Features on CT Are Prognostic of Recurrence as Well as Predictive of Added Benefit of Adjuvant Chemotherapy in ES-NSCLC

Journal of Thoracic Oncology

English

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

Journal of Thoracic Oncology

English

Persistent Molecular Remission of Refractory Acute Myeloid Leukemia With Inv(16)(p13.1q22) in an Elderly Patient Induced by Cytarabine Ocfosfate Hydrate

Journal of Hematology and Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P1.13-14 the Molecular Landscape of Lung Adenocarcinomas With Activating EGFR Gene Mutations Determined by Targeted-Sequencing

P1.15-13 Wait Times for Diagnosis and Treatment of Lung Cancer Across the Province of Quebec, Canada

P2.01-55 Dual-Energy CT Scan to Evaluate Sarcopenia in Lung Cancer in Comparison With Conventional CT Scan

P1.14-06 Treatment Outcomes of Patients With Thymic Carcinoma: A Monocentric Experience of Sequential Regimens Modality

P1.15-20 Diagnosis and Treatment Delay Among Patients With Lung Cancer in Mexican Population

P3.03-12 Cyclic Mechanical Strain and Myoferlin Modulates Lung Adenocarcinoma Cell Proliferation and Erlotinib Resistance

P1.16-45 Thoracoscopic Stapler-Based Complex Segmentectomy Assisted by Virtual Assisted Lung Mapping

P3.16-10 Radiomic Features on CT Are Prognostic of Recurrence as Well as Predictive of Added Benefit of Adjuvant Chemotherapy in ES-NSCLC

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

Persistent Molecular Remission of Refractory Acute Myeloid Leukemia With Inv(16)(p13.1q22) in an Elderly Patient Induced by Cytarabine Ocfosfate Hydrate